Access to anti-retroviral drugs, male in Guatemala
Guatemala: Access to anti-retroviral drugs, male was 82.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Guatemala, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Guatemala is 82.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 2.5% on the previous year and up 49.1% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Guatemala peaked at 82.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Guatemala 42nd out of 141 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Guatemala, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 17.0% | — |
| 2004 | 16.0% | -5.9% |
| 2005 | 16.0% | +0.0% |
| 2006 | 25.0% | +56.2% |
| 2007 | 36.0% | +44.0% |
| 2008 | 44.0% | +22.2% |
| 2009 | 44.0% | +0.0% |
| 2010 | 48.0% | +9.1% |
| 2011 | 47.0% | -2.1% |
| 2012 | 54.0% | +14.9% |
| 2013 | 56.0% | +3.7% |
| 2014 | 55.0% | -1.8% |
| 2015 | 55.0% | +0.0% |
| 2016 | 56.0% | +1.8% |
| 2017 | 61.0% | +8.9% |
| 2018 | 69.0% | +13.1% |
| 2019 | 72.0% | +4.3% |
| 2020 | 73.0% | +1.4% |
| 2021 | 76.0% | +4.1% |
| 2022 | 78.0% | +2.6% |
| 2023 | 80.0% | +2.6% |
| 2024 | 82.0% | +2.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 19.8% | 0.0% | 44.0% | 10 |
| 2010s | 57.3% | 47.0% | 72.0% | 10 |
| 2020s | 77.8% | 73.0% | 82.0% | 5 |
Countries ranked near Guatemala
- 40 Luxembourg 83.0% compare
- 40 Tanzania, United Republic of 83.0% compare
- 42 Mozambique 82.0% compare
- 42 Portugal 82.0% compare
- 42 Sierra Leone 82.0% compare
More gender data for Guatemala
- Child population (UN estimates and projections) 5,681 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.5138 % change on previous year (2030)
- Population 14,386 (2030)
- Working-age population (UN estimates and projections) 14,386 (2030)
- Population (UN estimates and projections), annual growth rate 2.14 % change on previous year (2030)
- Age population, age 00, female, interpolated 183,639 (2025)
- Age population, age 00, male, interpolated 190,265 (2025)
- Age population, age 01, female, interpolated 182,353 (2025)
- Age population, age 01, male, interpolated 188,776 (2025)
- Age population, age 02, female, interpolated 181,168 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Guatemala?
- Access to anti-retroviral drugs, male in Guatemala was 82.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Guatemala?
- The highest recorded value was 82.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Guatemala?
- The lowest recorded value was 0.0% in 2000.
- How does Guatemala rank for access to anti-retroviral drugs, male?
- Guatemala ranks 42nd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Guatemala?
- Over the last ten years it is up 49.1%. The long-run trend across the full record is volatile.
- Where does this Guatemala data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.